On April 1, 2026, Abeona Therapeutics Inc. expanded its Board from nine to ten members, appointing Keith A. Goldan as a Class 1 director and Chair of the Audit Committee, with an annual fee of $50,000 and a one-time equity grant worth $150,000. A press release regarding this appointment was issued on April 7, 2026.